Research and development

From startup to GMP manufacturing: Azzur's unique modular approach

Meet Ravi Samavedam, Chief Innovation Officer at Azzur Group, the US company supporting early phase manufacturers.
Ravi Samavedam of Azzur Group
Ravi Samavedam of Azzur Group
Table of Contents
In: Research and development

Ravi Samavedam, Chief Innovation Officer at Azzur Group, discusses his transition from big pharma to assisting startups with GMP manufacturing and the importance of flexible, modular facilities for innovative therapies. He highlights the need for better collaboration between the life sciences and real estate sectors, emphasizing the role of education and innovative models like clean rooms on demand to expedite therapy development.

Helping startups scale up to GMP manufacturing

Ravi, before we dive into our questions, could you briefly introduce yourself?

Certainly. I'm Ravi Samavedam, Chief Innovation Officer at Azzur Group. I've been in the industry for about 24 years, mainly with big pharmaceutical companies like Amgen, Baxter, and Shire. At Azzur, I now focus on helping startups navigate the complexities of GMP (Good Manufacturing Practices) and find the right partners for manufacturing. I'm also a co-founder of Azzur Clean Rooms on Demand (one of Azzur's five services) which addresses the growing need for manufacturing space and expertise.

Your work with startups must be quite a departure from your big pharma background.

Absolutely. Startups often struggle with the transition to GMP manufacturing, facing new regulations and quality demands. Traditionally, they had two options: build expensive facilities or outsource to contract manufacturers. Both had their challenges, including time and expertise gaps. In 2017, we recognised this problem and started offering fully equipped clean rooms and GMP services to startups, reducing the time it takes to get their therapies to clinical trials.

More from Life Sciences Real Estate

Stay on top of the life sciences real estate markets in Europe

Join us
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to Life Sciences Real Estate.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.